LianBio Deferred Tax Assets, Valuation Allowance
LianBio (LIANY) had Deferred Tax Assets, Valuation Allowance of $13.50 million as of 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2023-03-28
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $13.50M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $9.58M.
- 2020-12-31: Deferred Tax Assets, Valuation Allowance $43.06M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2022-12-31 | $13.50M 10-K · filed 2023-03-28 |
| 2021-12-31 | $9.58M 10-K · filed 2023-03-28 |
| 2020-12-31 | $43.06M 10-K · filed 2022-03-31 |